KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Gross Margin (2016 - 2026)

Globus Medical filings provide 15 years of Gross Margin readings, the most recent being 68.41% for Q4 2025.

  • On a quarterly basis, Gross Margin rose 848.0% to 68.41% in Q4 2025 year-over-year; TTM through Dec 2025 was 67.41%, a 851.0% increase, with the full-year FY2025 number at 67.41%, up 851.0% from a year prior.
  • Gross Margin hit 68.41% in Q4 2025 for Globus Medical, up from 67.16% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 75.8% in Q1 2021 to a low of 56.77% in Q3 2024.
  • Median Gross Margin over the past 5 years was 71.09% (2023), compared with a mean of 68.6%.
  • Biggest five-year swings in Gross Margin: tumbled -1734bps in 2023 and later skyrocketed 1040bps in 2025.
  • Globus Medical's Gross Margin stood at 75.28% in 2021, then decreased by -1bps to 74.28% in 2022, then dropped by -23bps to 56.94% in 2023, then grew by 5bps to 59.92% in 2024, then rose by 14bps to 68.41% in 2025.
  • The last three reported values for Gross Margin were 68.41% (Q4 2025), 67.16% (Q3 2025), and 66.62% (Q2 2025) per Business Quant data.